Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
By leveraging historical analysis and forecast projections, this study offers a holistic understanding of market developments, assisting stakeholders in making informed strategic decisions. Additionally, a SWOT analysis is incorporated to highlight strengths, weaknesses, opportunities, and threats within the sector.
The evolving U.S. tariff policy in 2025 is bringing considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the world, assessing their impacts on Biosimilars Drug market competitiveness, regional economic interdependencies, and supply chain reconfigurations.
Biosimilars Drug Market Segmentation
Market segmentation in research is the process of breaking down a broad market into distinct consumer groups based on shared characteristics, such as demographics, geographic location, behavioral patterns, or lifestyle preferences. This approach enables businesses to refine their product offerings and marketing strategies to better address the unique needs of each segment. By tailoring their approach, companies can optimize resource allocation, enhance customer satisfaction, and drive sales growth, ultimately securing a competitive advantage. Effective segmentation helps businesses gain deeper insights into their audience, craft targeted strategies, and maximize overall market performance.
Biosimilars Drug Market by Type [Analysis by Value from 2020 to ]:
- Monoclonal
- Erythropoietin
- Hormones
- Fusion Proteins
Biosimilars Drug Market by Application [Analysis by Value from 2020 to ]:
- Rheumatoid Arthritis
- Oncology
- Diabetes
- Autoimmune Disorders
Key Players in the Biosimilars Drug Market
Leading market players are focused on strengthening their presence by acquiring emerging companies. Established firms are heavily investing in research and development to introduce innovative products and expand their market reach. Additionally, some companies are engaging in mergers to leverage their combined strengths and deliver high-quality products. Based on these factors, the study includes the following key industry players.
- Pfizer
- Amgen
- Samsung Bioepis
- Sandoz
- Biocon
Biosimilars Drug Market Dynamics: Drivers & Restraints
The report meticulously examines the core growth factors and challenges influencing market expansion. Each variable is supported by qualitative and quantitative insights, with Harvey ball indicators representing their level of impact.
Biosimilars Drug Market Analysis & Industry Trends
A comprehensive overview of industry developments, regulatory updates, and structural market shifts is provided. The report also evaluates the impact of U.S. tariff policy on global demand fluctuations and recovery patterns.
Biosimilars Drug Market Size & Demand Forecast ()
Precise market sizing data and demand forecasts are included, covering year-on-year (YoY) growth rates and compound annual growth rate (CAGR) projections, enabling businesses to plan for future growth.
Biosimilars Drug Industry Supply Chain & Competitive Analysis
Using Porter’s Five Forces framework, the report assesses competitive intensity and profitability within the industry. A detailed supply chain analysis examines market participants, operational structures, and efficiency factors.
Biosimilars Drug Segmentation & Growth Forecasts
The study systematically breaks down the Global Biosimilars Drug Market into multiple segments, outlining current conditions and future growth trajectories. This helps identify emerging trends and lucrative opportunities.
Regional Market Insights
The report offers country-wise assessments of market drivers, regulatory frameworks, and growth prospects across key regions:
• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Russia)
• Asia-Pacific (China, India, Japan, South Korea, Australia)
• Rest of the World (Saudi Arabia, Brazil, Nigeria, South Africa)
Competitive Landscape & Key Player Profiles
Detailed evaluations of major companies include:
• Business overview & product offerings
• Financial performance & investment trends
• Recent mergers, acquisitions, and joint ventures (JVs)
• Strategic approaches adopted by market leaders
Executive Summary & Actionable Recommendations
A concise summary featuring charts, infographics, and forward-looking forecasts is provided. The report concludes with strategic recommendations to guide market stakeholders in decision-making.
Why Invest in This Biosimilars Drug Market Report?
✔️ Gain valuable insights into how COVID-19 has influenced the Biosimilars Drug market.
✔️ Discover market opportunities across key global regions.
✔️ Evaluate growth drivers & restraints and their long-term impact.
✔️ Access comprehensive market sizing & forecasting data.
✔️ Stay ahead of industry trends & competitive strategies.
✔️ Monitor M&A activities, partnerships, and joint ventures shaping the market.
For expert insights and customized segmentation, contact us to tailor the report to your specific business needs.
1 Market Overview
1.1 Product Overview and Scope of Biosimilars Drug
1.2 Global Biosimilars Drug Market Size and Forecast
1.3 China Biosimilars Drug Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Biosimilars Drug Share in Global Market, 2018-2029
1.4.2 Biosimilars Drug Market Size: China VS Global, 2018-2029
1.5 Biosimilars Drug Market Dynamics
1.5.1 Biosimilars Drug Market Drivers
1.5.2 Biosimilars Drug Market Restraints
1.5.3 Biosimilars Drug Industry Trends
1.5.4 Biosimilars Drug Industry Policy
2 Global Competitive Situation by Company
2.1 Global Biosimilars Drug Revenue by Company (2018-2023)
2.2 Global Biosimilars Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Biosimilars Drug Concentration Ratio
2.4 Global Biosimilars Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Biosimilars Drug Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Biosimilars Drug Revenue by Company (2018-2023)
3.2 China Biosimilars Drug Biosimilars Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Biosimilars Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Biosimilars Drug Industry Chain
4.2 Biosimilars Drug Upstream Analysis
4.3 Biosimilars Drug Midstream Analysis
4.4 Biosimilars Drug Downstream Analysis
5 Sights by Type
5.1 Biosimilars Drug Classification
5.1.1 Monoclonal Antibodies
5.1.2 Insulin
5.1.3 Others
5.2 By Type, Global Biosimilars Drug Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Biosimilars Drug Revenue, 2018-2029
6 Sights by Application
6.1 Biosimilars Drug Segment by Application
6.1.1 Hospital
6.1.2 Retail Pharmacy
6.1.3 Other
6.2 By Application, Global Biosimilars Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Biosimilars Drug Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Biosimilars Drug Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Biosimilars Drug Market Size, 2018-2029
7.3 North America
7.3.1 North America Biosimilars Drug Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Biosimilars Drug Market Size Market Share
7.4 Europe
7.4.1 Europe Biosimilars Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Biosimilars Drug Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Biosimilars Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Biosimilars Drug Market Size Market Share
7.6 South America
7.6.1 South America Biosimilars Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Biosimilars Drug Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Biosimilars Drug Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Biosimilars Drug Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Biosimilars Drug Market Size, 2018-2029
8.3.2 By Company, U.S. Biosimilars Drug Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Biosimilars Drug Market Size, 2018-2029
8.4.2 By Company, Europe Biosimilars Drug Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Biosimilars Drug Market Size, 2018-2029
8.5.2 By Company, China Biosimilars Drug Revenue Market Share, 2018-2023
8.5.3 By Type, China Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Biosimilars Drug Market Size, 2018-2029
8.6.2 By Company, Japan Biosimilars Drug Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Biosimilars Drug Market Size, 2018-2029
8.7.2 By Company, South Korea Biosimilars Drug Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Biosimilars Drug Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Biosimilars Drug Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Biosimilars Drug Market Size, 2018-2029
8.9.2 By Company, India Biosimilars Drug Revenue Market Share, 2018-2023
8.9.3 By Type, India Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Biosimilars Drug Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Biosimilars Drug Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Qilu Pharmaceutical
9.1.1 Qilu Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.1.2 Qilu Pharmaceutical Company Profile and Main Business
9.1.3 Qilu Pharmaceutical Biosimilars Drug Models, Specifications and Application
9.1.4 Qilu Pharmaceutical Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.1.5 Qilu Pharmaceutical Recent Developments
9.2 Bio-Thera
9.2.1 Bio-Thera Company Information, Head Office, Market Area and Industry Position
9.2.2 Bio-Thera Company Profile and Main Business
9.2.3 Bio-Thera Biosimilars Drug Models, Specifications and Application
9.2.4 Bio-Thera Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.2.5 Bio-Thera Recent Developments
9.3 Zhejiang Hisun
9.3.1 Zhejiang Hisun Company Information, Head Office, Market Area and Industry Position
9.3.2 Zhejiang Hisun Company Profile and Main Business
9.3.3 Zhejiang Hisun Biosimilars Drug Models, Specifications and Application
9.3.4 Zhejiang Hisun Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.3.5 Zhejiang Hisun Recent Developments
9.4 Shanghai Henlius
9.4.1 Shanghai Henlius Company Information, Head Office, Market Area and Industry Position
9.4.2 Shanghai Henlius Company Profile and Main Business
9.4.3 Shanghai Henlius Biosimilars Drug Models, Specifications and Application
9.4.4 Shanghai Henlius Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.4.5 Shanghai Henlius Recent Developments
9.5 Innovent Biologics
9.5.1 Innovent Biologics Company Information, Head Office, Market Area and Industry Position
9.5.2 Innovent Biologics Company Profile and Main Business
9.5.3 Innovent Biologics Biosimilars Drug Models, Specifications and Application
9.5.4 Innovent Biologics Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.5.5 Innovent Biologics Recent Developments
9.6 Jiangsu Hengrui
9.6.1 Jiangsu Hengrui Company Information, Head Office, Market Area and Industry Position
9.6.2 Jiangsu Hengrui Company Profile and Main Business
9.6.3 Jiangsu Hengrui Biosimilars Drug Models, Specifications and Application
9.6.4 Jiangsu Hengrui Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.6.5 Jiangsu Hengrui Recent Developments
9.7 Gan&Lee
9.7.1 Gan&Lee Company Information, Head Office, Market Area and Industry Position
9.7.2 Gan&Lee Company Profile and Main Business
9.7.3 Gan&Lee Biosimilars Drug Models, Specifications and Application
9.7.4 Gan&Lee Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.7.5 Gan&Lee Recent Developments
9.8 Tonghua Dongbao
9.8.1 Tonghua Dongbao Company Information, Head Office, Market Area and Industry Position
9.8.2 Tonghua Dongbao Company Profile and Main Business
9.8.3 Tonghua Dongbao Biosimilars Drug Models, Specifications and Application
9.8.4 Tonghua Dongbao Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.8.5 Tonghua Dongbao Recent Developments
9.9 United Laboratory
9.9.1 United Laboratory Company Information, Head Office, Market Area and Industry Position
9.9.2 United Laboratory Company Profile and Main Business
9.9.3 United Laboratory Biosimilars Drug Models, Specifications and Application
9.9.4 United Laboratory Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.9.5 United Laboratory Recent Developments
9.10 3SBIO
9.10.1 3SBIO Company Information, Head Office, Market Area and Industry Position
9.10.2 3SBIO Company Profile and Main Business
9.10.3 3SBIO Biosimilars Drug Models, Specifications and Application
9.10.4 3SBIO Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.10.5 3SBIO Recent Developments
9.11 Luye Pharma
9.11.1 Luye Pharma Company Information, Head Office, Market Area and Industry Position
9.11.2 Luye Pharma Company Profile and Main Business
9.11.3 Luye Pharma Biosimilars Drug Models, Specifications and Application
9.11.4 Luye Pharma Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.11.5 Luye Pharma Recent Developments
9.12 Celltrion
9.12.1 Celltrion Company Information, Head Office, Market Area and Industry Position
9.12.2 Celltrion Company Profile and Main Business
9.12.3 Celltrion Biosimilars Drug Models, Specifications and Application
9.12.4 Celltrion Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.12.5 Celltrion Recent Developments
9.13 Pfizer
9.13.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.13.2 Pfizer Company Profile and Main Business
9.13.3 Pfizer Biosimilars Drug Models, Specifications and Application
9.13.4 Pfizer Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.13.5 Pfizer Recent Developments
9.14 Novartis
9.14.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.14.2 Novartis Company Profile and Main Business
9.14.3 Novartis Biosimilars Drug Models, Specifications and Application
9.14.4 Novartis Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.14.5 Novartis Recent Developments
9.15 Dr Reddy’s
9.15.1 Dr Reddy’s Company Information, Head Office, Market Area and Industry Position
9.15.2 Dr Reddy’s Company Profile and Main Business
9.15.3 Dr Reddy’s Biosimilars Drug Models, Specifications and Application
9.15.4 Dr Reddy’s Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.15.5 Dr Reddy’s Recent Developments
9.16 Celgen Biopharma
9.16.1 Celgen Biopharma Company Information, Head Office, Market Area and Industry Position
9.16.2 Celgen Biopharma Company Profile and Main Business
9.16.3 Celgen Biopharma Biosimilars Drug Models, Specifications and Application
9.16.4 Celgen Biopharma Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.16.5 Celgen Biopharma Recent Developments
9.17 Eli Lilly
9.17.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position
9.17.2 Eli Lilly Company Profile and Main Business
9.17.3 Eli Lilly Biosimilars Drug Models, Specifications and Application
9.17.4 Eli Lilly Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.17.5 Eli Lilly Recent Developments
9.18 Sanofi
9.18.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.18.2 Sanofi Company Profile and Main Business
9.18.3 Sanofi Biosimilars Drug Models, Specifications and Application
9.18.4 Sanofi Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.18.5 Sanofi Recent Developments
9.19 Geropharm
9.19.1 Geropharm Company Information, Head Office, Market Area and Industry Position
9.19.2 Geropharm Company Profile and Main Business
9.19.3 Geropharm Biosimilars Drug Models, Specifications and Application
9.19.4 Geropharm Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.19.5 Geropharm Recent Developments
9.20 Biocon
9.20.1 Biocon Company Information, Head Office, Market Area and Industry Position
9.20.2 Biocon Company Profile and Main Business
9.20.3 Biocon Biosimilars Drug Models, Specifications and Application
9.20.4 Biocon Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.20.5 Biocon Recent Developments
9.21 Wockhardt
9.21.1 Wockhardt Company Information, Head Office, Market Area and Industry Position
9.21.2 Wockhardt Company Profile and Main Business
9.21.3 Wockhardt Biosimilars Drug Models, Specifications and Application
9.21.4 Wockhardt Biosimilars Drug Revenue and Gross Margin, 2018-2023
9.21.5 Wockhardt Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Biosimilars Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Biosimilars Drug Market Restraints
Table 3. Biosimilars Drug Market Trends
Table 4. Biosimilars Drug Industry Policy
Table 5. Global Biosimilars Drug Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Biosimilars Drug Revenue Market Share by Company (2018-2023)
Table 7. Global Biosimilars Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Biosimilars Drug Mergers & Acquisitions, Expansion Plans
Table 9. Global Biosimilars Drug Manufacturers Product Type
Table 10. China Biosimilars Drug Revenue by Company (2018-2023) & (US$ million)
Table 11. China Biosimilars Drug Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Biosimilars Drug Upstream (Raw Materials)
Table 13. Global Biosimilars Drug Typical Customers
Table 14. Biosimilars Drug Typical Distributors
Table 15. By Type, Global Biosimilars Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Biosimilars Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Biosimilars Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Biosimilars Drug Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Biosimilars Drug Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Biosimilars Drug Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Biosimilars Drug Revenue Market Share, 2018-2029
Table 22. Qilu Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 23. Qilu Pharmaceutical Company Profile and Main Business
Table 24. Qilu Pharmaceutical Biosimilars Drug Models, Specifications and Application
Table 25. Qilu Pharmaceutical Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 26. Qilu Pharmaceutical Recent Developments
Table 27. Bio-Thera Company Information, Head Office, Market Area and Industry Position
Table 28. Bio-Thera Company Profile and Main Business
Table 29. Bio-Thera Biosimilars Drug Models, Specifications and Application
Table 30. Bio-Thera Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 31. Bio-Thera Recent Developments
Table 32. Zhejiang Hisun Company Information, Head Office, Market Area and Industry Position
Table 33. Zhejiang Hisun Company Profile and Main Business
Table 34. Zhejiang Hisun Biosimilars Drug Models, Specifications and Application
Table 35. Zhejiang Hisun Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 36. Zhejiang Hisun Recent Developments
Table 37. Shanghai Henlius Company Information, Head Office, Market Area and Industry Position
Table 38. Shanghai Henlius Company Profile and Main Business
Table 39. Shanghai Henlius Biosimilars Drug Models, Specifications and Application
Table 40. Shanghai Henlius Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 41. Shanghai Henlius Recent Developments
Table 42. Innovent Biologics Company Information, Head Office, Market Area and Industry Position
Table 43. Innovent Biologics Company Profile and Main Business
Table 44. Innovent Biologics Biosimilars Drug Models, Specifications and Application
Table 45. Innovent Biologics Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 46. Innovent Biologics Recent Developments
Table 47. Jiangsu Hengrui Company Information, Head Office, Market Area and Industry Position
Table 48. Jiangsu Hengrui Company Profile and Main Business
Table 49. Jiangsu Hengrui Biosimilars Drug Models, Specifications and Application
Table 50. Jiangsu Hengrui Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 51. Jiangsu Hengrui Recent Developments
Table 52. Gan&Lee Company Information, Head Office, Market Area and Industry Position
Table 53. Gan&Lee Company Profile and Main Business
Table 54. Gan&Lee Biosimilars Drug Models, Specifications and Application
Table 55. Gan&Lee Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 56. Gan&Lee Recent Developments
Table 57. Tonghua Dongbao Company Information, Head Office, Market Area and Industry Position
Table 58. Tonghua Dongbao Company Profile and Main Business
Table 59. Tonghua Dongbao Biosimilars Drug Models, Specifications and Application
Table 60. Tonghua Dongbao Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 61. Tonghua Dongbao Recent Developments
Table 62. United Laboratory Company Information, Head Office, Market Area and Industry Position
Table 63. United Laboratory Company Profile and Main Business
Table 64. United Laboratory Biosimilars Drug Models, Specifications and Application
Table 65. United Laboratory Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 66. United Laboratory Recent Developments
Table 67. 3SBIO Company Information, Head Office, Market Area and Industry Position
Table 68. 3SBIO Company Profile and Main Business
Table 69. 3SBIO Biosimilars Drug Models, Specifications and Application
Table 70. 3SBIO Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 71. 3SBIO Recent Developments
Table 72. Luye Pharma Company Information, Head Office, Market Area and Industry Position
Table 73. Luye Pharma Company Profile and Main Business
Table 74. Luye Pharma Biosimilars Drug Models, Specifications and Application
Table 75. Luye Pharma Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 76. Luye Pharma Recent Developments
Table 77. Celltrion Company Information, Head Office, Market Area and Industry Position
Table 78. Celltrion Company Profile and Main Business
Table 79. Celltrion Biosimilars Drug Models, Specifications and Application
Table 80. Celltrion Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 81. Celltrion Recent Developments
Table 82. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 83. Pfizer Company Profile and Main Business
Table 84. Pfizer Biosimilars Drug Models, Specifications and Application
Table 85. Pfizer Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 86. Pfizer Recent Developments
Table 87. Novartis Company Information, Head Office, Market Area and Industry Position
Table 88. Novartis Company Profile and Main Business
Table 89. Novartis Biosimilars Drug Models, Specifications and Application
Table 90. Novartis Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 91. Novartis Recent Developments
Table 92. Dr Reddy’s Company Information, Head Office, Market Area and Industry Position
Table 93. Dr Reddy’s Company Profile and Main Business
Table 94. Dr Reddy’s Biosimilars Drug Models, Specifications and Application
Table 95. Dr Reddy’s Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 96. Dr Reddy’s Recent Developments
Table 97. Celgen Biopharma Company Information, Head Office, Market Area and Industry Position
Table 98. Celgen Biopharma Company Profile and Main Business
Table 99. Celgen Biopharma Biosimilars Drug Models, Specifications and Application
Table 100. Celgen Biopharma Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 101. Celgen Biopharma Recent Developments
Table 102. Eli Lilly Company Information, Head Office, Market Area and Industry Position
Table 103. Eli Lilly Company Profile and Main Business
Table 104. Eli Lilly Biosimilars Drug Models, Specifications and Application
Table 105. Eli Lilly Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 106. Eli Lilly Recent Developments
Table 107. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 108. Sanofi Company Profile and Main Business
Table 109. Sanofi Biosimilars Drug Models, Specifications and Application
Table 110. Sanofi Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 111. Sanofi Recent Developments
Table 112. Geropharm Company Information, Head Office, Market Area and Industry Position
Table 113. Geropharm Company Profile and Main Business
Table 114. Geropharm Biosimilars Drug Models, Specifications and Application
Table 115. Geropharm Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 116. Geropharm Recent Developments
Table 117. Biocon Company Information, Head Office, Market Area and Industry Position
Table 118. Biocon Company Profile and Main Business
Table 119. Biocon Biosimilars Drug Models, Specifications and Application
Table 120. Biocon Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 121. Biocon Recent Developments
Table 122. Wockhardt Company Information, Head Office, Market Area and Industry Position
Table 123. Wockhardt Company Profile and Main Business
Table 124. Wockhardt Biosimilars Drug Models, Specifications and Application
Table 125. Wockhardt Biosimilars Drug Revenue and Gross Margin, 2018-2023
Table 126. Wockhardt Recent Developments
List of Figure
Figure 1. Biosimilars Drug Picture
Figure 2. Global Biosimilars Drug Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Biosimilars Drug Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Biosimilars Drug Market Share of Global
Figure 5. Global Biosimilars Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Biosimilars Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Biosimilars Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Biosimilars Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Biosimilars Drug Industry Chain
Figure 10. Monoclonal Antibodies
Figure 11. Insulin
Figure 12. Others
Figure 13. By Type, Global Biosimilars Drug Revenue, 2018-2029, US$ Million
Figure 14. By Type, Global Biosimilars Drug Revenue Market Share, 2018-2029
Figure 15. Hospital
Figure 16. Retail Pharmacy
Figure 17. Other
Figure 18. By Application, Global Biosimilars Drug Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global Biosimilars Drug Revenue Market Share, 2018-2029
Figure 20. By Region, Global Biosimilars Drug Revenue Market Share, 2018-2029
Figure 21. North America Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Biosimilars Drug Revenue Market Share, 2018-2023
Figure 23. Europe Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Biosimilars Drug Revenue Market Share, 2018-2023
Figure 25. Asia Pacific Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Biosimilars Drug Revenue Market Share, 2018-2023
Figure 27. South America Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Biosimilars Drug Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa Biosimilars Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Biosimilars Drug Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. Biosimilars Drug Market Share, 2018-2023
Figure 32. By Type, U.S. Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 34. Europe Biosimilars Drug Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe Biosimilars Drug Market Share, 2018-2023
Figure 36. By Type, Europe Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 38. China Biosimilars Drug Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China Biosimilars Drug Market Share, 2018-2023
Figure 40. By Type, China Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 42. Japan Biosimilars Drug Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan Biosimilars Drug Market Share, 2018-2023
Figure 44. By Type, Japan Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 46. South Korea Biosimilars Drug Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea Biosimilars Drug Market Share, 2018-2023
Figure 48. By Type, South Korea Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia Biosimilars Drug Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia Biosimilars Drug Market Share, 2018-2023
Figure 52. By Type, Southeast Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 54. India Biosimilars Drug Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India Biosimilars Drug Market Share, 2018-2023
Figure 56. By Type, India Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia Biosimilars Drug Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia Biosimilars Drug Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia Biosimilars Drug Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches
Research Methodology:
Biosimilars Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|